NHS Sickle Cell & Thalassaemia Screening Programme

The NHS' Standards for the linked antenatal and newborn screening programme

NHS

Standards for Sickle Cell & Thalasseamia Screening Programme

Articles

Discover other Patient & Caregivers Articles

SCAGO

Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY® (Exagamglogene Autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

SCAGO

Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY® (Exagamglogene Autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

SCAGO

Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY® (Exagamglogene Autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) From Worldwide Markets

Youth in Pain

Short-Acting Opioid Analgesics for Pain Management

Youth in Pain

Short-Acting Opioid Analgesics for Pain Management

Youth in Pain

Short-Acting Opioid Analgesics for Pain Management

Jacob Pendergrast, MD, FRCPC

Blood Transfusion in Sickle Cell Disease

Improving the knowledge of peers and families about blood transfusion in sickle cell disease

Jacob Pendergrast, MD, FRCPC

Blood Transfusion in Sickle Cell Disease

Improving the knowledge of peers and families about blood transfusion in sickle cell disease

Jacob Pendergrast, MD, FRCPC

Blood Transfusion in Sickle Cell Disease

Improving the knowledge of peers and families about blood transfusion in sickle cell disease

Dr. Robert Klaassen

Pain Management

The Role of Parents & Family Members in sickle cell disease pain management

Dr. Robert Klaassen

Pain Management

The Role of Parents & Family Members in sickle cell disease pain management

Dr. Robert Klaassen

Pain Management

The Role of Parents & Family Members in sickle cell disease pain management

Dr. Julie Beaulac, Ph.D., C. Psych.

Adherence to treatment

Improving care and treatment by utilising informed decision making based on pateint preferences and best practices.

Dr. Julie Beaulac, Ph.D., C. Psych.

Adherence to treatment

Improving care and treatment by utilising informed decision making based on pateint preferences and best practices.

Dr. Julie Beaulac, Ph.D., C. Psych.

Adherence to treatment

Improving care and treatment by utilising informed decision making based on pateint preferences and best practices.

Quick Links

Home

Get Involved

SCAGO Online

Location

Address: 235-415 Oakdale Rd. North York, ON M3N 1W7

Phone: GTA: 416-745-4267

Email: info@sicklecellanemia.ca

Got a Question?

Want to Support Us?

Donate Now

Quick Links

Home

Get Involved

SCAGO Online

Location

Address: 235-415 Oakdale Rd.

North York, ON M3N 1W7

Phone: 416-745-4267

Email: info@sicklecellanemia.ca

Got a Question?

Want to Support Us?

Donate Now

Quick Links

Home

Get Involved

SCAGO Online

Location

Address: 235-415 Oakdale Rd. North York, ON M3N 1W7

Phone: 416-745-4267

Email: info@sicklecellanemia.ca

Got a Question?

Want to Support Us?

Donate Now